- Home
- IDYA vs INDB Comparison
IDYA vs INDB Comparison
Compare IDYA & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- INDB
- Stock Information
- Founded
- IDYA 2015
- INDB 1907
- Country
- IDYA United States
- INDB United States
- Employees
- IDYA N/A
- INDB N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- INDB Major Banks
- Sector
- IDYA Health Care
- INDB Finance
- Exchange
- IDYA Nasdaq
- INDB Nasdaq
- Market Cap
- IDYA 2.6B
- INDB 2.4B
- IPO Year
- IDYA 2019
- INDB N/A
- Fundamental
- Price
- IDYA $26.64
- INDB $72.22
- Analyst Decision
- IDYA Strong Buy
- INDB Strong Buy
- Analyst Count
- IDYA 12
- INDB 3
- Target Price
- IDYA $53.08
- INDB $68.00
- AVG Volume (30 Days)
- IDYA 750.9K
- INDB 310.6K
- Earning Date
- IDYA 11-04-2024
- INDB 10-17-2024
- Dividend Yield
- IDYA N/A
- INDB 3.16%
- EPS Growth
- IDYA N/A
- INDB N/A
- EPS
- IDYA N/A
- INDB 4.60
- Revenue
- IDYA $3,922,000.00
- INDB $655,494,000.00
- Revenue This Year
- IDYA N/A
- INDB N/A
- Revenue Next Year
- IDYA $158.10
- INDB $5.18
- P/E Ratio
- IDYA N/A
- INDB $15.70
- Revenue Growth
- IDYA N/A
- INDB N/A
- 52 Week Low
- IDYA $26.41
- INDB $45.11
- 52 Week High
- IDYA $47.74
- INDB $75.63
- Technical
- Relative Strength Index (RSI)
- IDYA 33.96
- INDB 65.60
- Support Level
- IDYA $27.52
- INDB $70.14
- Resistance Level
- IDYA $32.67
- INDB $75.63
- Average True Range (ATR)
- IDYA 1.44
- INDB 2.34
- MACD
- IDYA -0.04
- INDB 0.61
- Stochastic Oscillator
- IDYA 3.75
- INDB 76.53
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers, and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.